Influenza

William Schaffner, MD, discusses how the adults aged 65 and older are disproportionately affected by influenza.

A multinational team of researchers set out to answer the following question when it comes to antiviral therapy for influenza: to combine or not to combine?

A new article details how researchers are working to develop a universal flu shot.

Pandemic influenza virus strains easily infect humans and spread from person-to-person in an efficient and sustained way. With no immunity to the novel virus and no vaccine to protect against it, what will the United States do?

New tests continue to evolve that offer greater sensitivity than current methods.

Flu season has officially begun in the United States, as the first cases and deaths of the season are reported, prompting health officials to press for vaccination.

News about the Zika virus dominated our top articles for the month of September 2017. Did you read them all?

William Schaffner, MD, medical director for the National Foundation for Infectious Diseases’ (NFID), provides a brief overview of the past flu season (2016-2017).

In a new study reviewing existing literature, researchers have found that more than 2 dozen viruses have been detected in human semen.

In a recent updated report, the Centers for Disease Control and Prevention’s Global Disease Detection Operations Center identifies the most recent public health threats, including those that could lead to a pandemic.

The CDC shares ACIP’s recommendations regarding the prevention and control of seasonal influenza with vaccines for the 2017-2018 season.

A recent study investigates what causes relapse in those with multiple sclerosis and sought to glean insight into the brain activity of patients with MS during respiratory infections.

In a new study published in the journal Vaccine, researchers examine the antibody response to the flu vaccine in pregnant women and their babies.

The results of a new study have revealed that that classic “beads on a string” model of the influenza A virus may not be entirely accurate.

A new report from the National Center for Health Statistics has found that too many adults aged 65 and older are missing out on important vaccinations.

The World Bank recently announced plans to issue “pandemic bonds and derivatives” to help fund its Pandemic Emergency Finance Facility, which will “channel surge funding” to at-risk countries in the developing world.

Scientists have identified 3 mutations that could allow the avian influenza strain H7N9 to spread among humans.

Researchers have developed an adhesive patch delivery method for the influenza vaccine and new study shows it is as effective as the flu shot.

The latest report from the Department of Health and Human Services reveals both good news and bad news on the health of our nation.

Building on lessons learned from the 2009 influenza A (H1N1) pandemic, the United States Department of Health and Human Services has released its updated Pandemic Influenza Plan for 2017-2027.

This week’s report includes the latest from Gilead, Janssen, Spero Therapeutics, Clorox, and TECHLAB.

In case you missed them, here are our top 5 articles for the week of May 28, 2017.

Lauri A. Hicks, DO, discusses keys to reducing antibiotic resistance.

A research team headed by Carl D’Angio, MD, a physician in the Department of Pediatrics at the University of Rochester Medical Center in Rochester, New York, compare flu vaccine response in PT versus FT infants.

Researchers from the University of Toronto evaluated 82 patients under 18 years of age from Toronto, Ottawa, Montreal, and Quebec.